$664 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 55 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ITCI | Exit | INTRA CELLULAR THERAPIES INCcall | $0 | – | -100,000 | -100.0% | -0.09% | – |
MITO | Exit | STEALTH BIOTHERAPEUTICS CORPsponsored ads | $0 | – | -398,169 | -100.0% | -0.28% | – |
AXSM | Exit | AXSOME THERAPEUTICS INCput | $0 | – | -150,000 | -100.0% | -0.36% | – |
AERI | Exit | AERIE PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.45% | – |
ARQL | Exit | ARQULE INC | $0 | – | -1,171,352 | -100.0% | -0.99% | – |
SGEN | Exit | SEATTLE GENETICS INCput | $0 | – | -100,000 | -100.0% | -1.01% | – |
HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -505,729 | -100.0% | -1.10% | – |
AGN | Exit | ALLERGAN PLC | $0 | – | -60,216 | -100.0% | -1.20% | – |
IAA | Exit | IAA INC | $0 | – | -288,838 | -100.0% | -1.42% | – |
DIS | Exit | DISNEY WALT COcall | $0 | – | -100,000 | -100.0% | -1.54% | – |
ZBRA | Exit | ZEBRA TECHNOLOGIES CORPcl a | $0 | – | -64,382 | -100.0% | -1.57% | – |
MED | Exit | MEDIFAST INC | $0 | – | -130,956 | -100.0% | -1.60% | – |
CP | Exit | CANADIAN PAC RY LTD | $0 | – | -68,088 | -100.0% | -1.79% | – |
UPS | Exit | UNITED PARCEL SERVICE INCcl b | $0 | – | -131,108 | -100.0% | -1.86% | – |
EDU | Exit | NEW ORIENTAL ED & TECH GRP Ispon adr | $0 | – | -146,996 | -100.0% | -1.92% | – |
AMZN | Exit | AMAZON COM INC | $0 | – | -9,840 | -100.0% | -2.02% | – |
FB | Exit | FACEBOOK INCcall | $0 | – | -100,000 | -100.0% | -2.10% | – |
MSI | Exit | MOTOROLA SOLUTIONS INC | $0 | – | -122,414 | -100.0% | -2.46% | – |
ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -184,631 | -100.0% | -2.48% | – |
IWM | Exit | ISHARES TRput | $0 | – | -140,000 | -100.0% | -2.50% | – |
BABA | Exit | ALIBABA GROUP HLDG LTDsponsored ads | $0 | – | -134,360 | -100.0% | -2.65% | – |
QQQ | Exit | INVESCO QQQ TRput | $0 | – | -137,500 | -100.0% | -3.07% | – |
CSTM | Exit | CONSTELLIUM SEcl a | $0 | – | -2,067,180 | -100.0% | -3.10% | – |
ARMK | Exit | ARAMARK | $0 | – | -605,371 | -100.0% | -3.12% | – |
MPC | Exit | MARATHON PETE CORP | $0 | – | -504,377 | -100.0% | -3.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
ISHARES TR | 27 | Q3 2023 | 13.2% |
HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
AMAZON COM INC | 18 | Q3 2022 | 7.6% |
SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-04-15 |
13F-HR/A | 2024-03-18 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2023-11-29 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.